1 – 8 of 8
- show: 10
- |
- sort: year (new to old)
Close
Embed this list
<iframe src=""
width=""
height=""
allowtransparency="true"
frameborder="0">
</iframe>
- 2019
- Test–retest repeatability of [18F]Flortaucipir PET in Alzheimer’s disease and cognitively normal individuals
- Associations between quantitative [18F]flortaucipir tau PET and atrophy across the Alzheimer's disease spectrum
- Discordant amyloid-β PET and CSF biomarkers and its clinical consequences
- Amyloid-β load is related to worries, but not to severity of cognitive complaints in individuals with subjective cognitive decline : The science project
- Amyloid PET and cognitive decline in cognitively normal individuals : the SCIENCe project
- 2018
- Clinical phenotype, atrophy, and small vessel disease in APOEε2 carriers with Alzheimer disease
- A novel partial volume correction method for accurate quantification of [18F] flortaucipir in the hippocampus
- Prevalence of the apolipoprotein E ε4 allele in amyloid β positive subjects across the spectrum of Alzheimer's disease